Schistosomiasis Clinical Trials

6 recruiting

Schistosomiasis Trials at a Glance

6 actively recruiting trials for schistosomiasis are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Almería, Antwerp, and Barcelona. Lead sponsors running schistosomiasis studies include IRCCS Sacro Cuore Don Calabria di Negrar, Chinese Pulmonary Vascular Disease Research Group, and Institut Pasteur du Cambodge.

Browse schistosomiasis trials by phase

Treatments under study

About Schistosomiasis Clinical Trials

Looking for clinical trials for Schistosomiasis? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Schistosomiasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Schistosomiasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

MATCHING - feMAle geniTal sCHistosomiasis IN miGrants Female Genital Schistosomiasis in Migrants Presenting to an Outpatient Clinic in Italy: Prevalence and Clinical Impact

Female Genital Schistosomiasis
IRCCS Sacro Cuore Don Calabria di Negrar96 enrolled1 locationNCT07484256
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting

Rutgers University Study of the Genetics of Pulmonary Hypertension

Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Arterial Hypertension of Congenital Heart Disease+5 more
Rutgers, The State University of New Jersey10,000 enrolled1 locationNCT07217522
Recruiting

Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study

Schistosomiasis
Peter Steinmann18,500 enrolled7 locationsNCT06698510
Recruiting
Not Applicable

Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis

Schistosomiasis
IRCCS Sacro Cuore Don Calabria di Negrar278 enrolled8 locationsNCT06873308
Recruiting

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Pulmonary HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Chinese Pulmonary Vascular Disease Research Group4,000 enrolled1 locationNCT02061787